Invention Grant
- Patent Title: PI3K gamma inhibitor peptide for treatment of respiratory system diseases
-
Application No.: US16911485Application Date: 2020-06-25
-
Publication No.: US11352400B2Publication Date: 2022-06-07
- Inventor: Emilio Hirsch , Alessandra Ghigo
- Applicant: Kither Biotech S.r.I.
- Applicant Address: IT Turin
- Assignee: Kither Biotech S.r.I.
- Current Assignee: Kither Biotech S.r.I.
- Current Assignee Address: IT Turin
- Agency: Nixon & Vanderhye, PC
- Priority: ITTO2014A001105 20141224
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A61P11/00 ; A61K38/00 ; A61K45/06
Abstract:
Fusion peptide comprising: i) an amino acid sequence as defined in SEQ ID No.: 1 or a related homolog having at least 90% identity with SEQ ID No.: 1 and having the ability of the sequence SEQ ID No.: 1 to inhibit the kinase-independent function of PI3Kγ, and ii) a peptide having the ability to penetrate a cell.
Public/Granted literature
- US20200317740A1 NOVEL PI3K GAMMA INHIBITOR PEPTIDE FOR TREATMENT OF RESPIRATORY SYSTEM DISEASES Public/Granted day:2020-10-08
Information query
